These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 29902577)

  • 21. Down-regulation of miR-24-3p in colorectal cancer is associated with malignant behavior.
    Gao Y; Liu Y; Du L; Li J; Qu A; Zhang X; Wang L; Wang C
    Med Oncol; 2015 Jan; 32(1):362. PubMed ID: 25502080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of aberrantly expressed miRNAs in rectal cancer.
    Li X; Zhang G; Luo F; Ruan J; Huang D; Feng D; Xiao D; Zeng Z; Chen X; Wu W
    Oncol Rep; 2012 Jul; 28(1):77-84. PubMed ID: 22576798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma.
    D'Angelo E; Fassan M; Maretto I; Pucciarelli S; Zanon C; Digito M; Rugge M; Nitti D; Agostini M
    Oncotarget; 2016 May; 7(19):28647-57. PubMed ID: 27081702
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression profile of miR-17/92 cluster is predictive of treatment response in rectal cancer.
    Kral J; Korenkova V; Novosadova V; Langerova L; Schneiderova M; Liska V; Levy M; Veskrnova V; Spicak J; Opattova A; Jiraskova K; Vymetalkova V; Vodicka P; Slyskova J
    Carcinogenesis; 2018 Dec; 39(11):1359-1367. PubMed ID: 30277504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis.
    Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W
    Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of Circulating miRNAs Expression Alterations in Matched Tissue and Plasma Samples During Colorectal Cancer Progression.
    Nagy ZB; Barták BK; Kalmár A; Galamb O; Wichmann B; Dank M; Igaz P; Tulassay Z; Molnár B
    Pathol Oncol Res; 2019 Jan; 25(1):97-105. PubMed ID: 28980150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
    Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M
    Oncology; 2016; 90(4):221-31. PubMed ID: 26999740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-tumor heterogeneity of microRNA-92a, microRNA-375 and microRNA-424 in colorectal cancer.
    Jepsen RK; Novotny GW; Klarskov LL; Christensen IJ; Riis LB; Høgdall E
    Exp Mol Pathol; 2016 Feb; 100(1):125-31. PubMed ID: 26681654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer.
    Arndt GM; Dossey L; Cullen LM; Lai A; Druker R; Eisbacher M; Zhang C; Tran N; Fan H; Retzlaff K; Bittner A; Raponi M
    BMC Cancer; 2009 Oct; 9():374. PubMed ID: 19843336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative Analysis of miRNA and EMT Markers in Metastatic Colorectal Cancer.
    Hanusova V; Matouskova P; Manethova M; Soukup J; John S; Zofka M; Vošmikova H; Krbal L; Rudolf E
    Cancer Invest; 2023 Dec; 41(10):837-847. PubMed ID: 37997798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
    Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
    Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer.
    Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C
    BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of microRNA 92a Expression and Its Target Protein Bim in Colorectal Cancer.
    Zaki A; Fawzy A; Akel SY; Gamal H; Elshimy RAA
    Asian Pac J Cancer Prev; 2022 Feb; 23(2):723-730. PubMed ID: 35225486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA expression profiles in human colorectal cancers with liver metastases.
    Lin M; Chen W; Huang J; Gao H; Ye Y; Song Z; Shen X
    Oncol Rep; 2011 Mar; 25(3):739-47. PubMed ID: 21174058
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-489 suppresses tumor growth and invasion by targeting HDAC7 in colorectal cancer.
    Gao S; Liu H; Hou S; Wu L; Yang Z; Shen J; Zhou L; Zheng SS; Jiang B
    Clin Transl Oncol; 2018 Jun; 20(6):703-712. PubMed ID: 29071516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA expression patterns of tumors in early-onset colorectal cancer patients.
    Ak S; Tunca B; Tezcan G; Cecener G; Egeli U; Yilmazlar T; Ozturk E; Yerci O
    J Surg Res; 2014 Sep; 191(1):113-22. PubMed ID: 24746948
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancer.
    Maierthaler M; Benner A; Hoffmeister M; Surowy H; Jansen L; Knebel P; Chang-Claude J; Brenner H; Burwinkel B
    Int J Cancer; 2017 Jan; 140(1):176-187. PubMed ID: 27632639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-409-3p suppresses colorectal cancer invasion and metastasis partly by targeting GAB1 expression.
    Bai R; Weng C; Dong H; Li S; Chen G; Xu Z
    Int J Cancer; 2015 Nov; 137(10):2310-22. PubMed ID: 25991585
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stool-Based miR-92a and miR-144* as Noninvasive Biomarkers for Colorectal Cancer Screening.
    Choi HH; Cho YS; Choi JH; Kim HK; Kim SS; Chae HS
    Oncology; 2019; 97(3):173-179. PubMed ID: 31216561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.